MedPath

Levocetirizine Dihydrochloride

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . tablets, for oral use Initial U.S. Approval: 1995

Approved
Approval ID

1efcf912-1187-4d69-895c-30d363e5eb7a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 23, 2018

Manufacturers
FDA

Aidarex Pharmaceuticals LLC

DUNS: 801503249

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levocetirizine Dihydrochloride

PRODUCT DETAILS

NDC Product Code53217-375
Application NumberANDA203027
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 23, 2018
Generic NameLevocetirizine Dihydrochloride

INGREDIENTS (9)

LEVOCETIRIZINE DIHYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: SOD6A38AGA
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
POLYETHYLENE GLYCOLSInactive
Code: 3WJQ0SDW1A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYDROXYPROPYL CELLULOSE (TYPE H)Inactive
Code: RFW2ET671P
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath